Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 5 49-5, 2004, Pages

  Suarez, Cecilia ^a   Díaz Torga, Graciela ^a   González Iglesias, Arturo ^a   Cristina, Carolina ^a   Becu Villalobos, Damasia ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Calcium signaling; Prolactin; Reverse transcriptase polymerase chain reaction; Western blot

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIETHYLSTILBESTROL; ESTROGEN; HYDROXYPROGESTERONE CAPROATE; PROGESTERONE; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERPITUITARISM; HYPOPHYSIS; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

17-ALPHA-HYDROXYPROGESTERONE; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM SIGNALING; DIETHYLSTILBESTROL; DOWN-REGULATION; ESTROGENS, NON-STEROIDAL; FEMALE; HYPERPLASIA; PITUITARY DISEASES; PITUITARY GLAND; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA, MESSENGER; UP-REGULATION;

EID: 1942518736     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00477.2003     Document Type: Article

References (53)

1. AbdAlla S, Lother H, Abdel-tawab AM, and Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276: 39721-39726, 2001.
2. AbdAlla S, Lother H, and Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407: 94-98, 2000.
3. 2 receptor gene disrupted mice. Neuroendocrinology 76: 137-147, 2002.
4. Becu-Villalobos D, Lacau-Mengido IM, Thyssen SM, Diaz-Torga GS, and Libertun C. Effects of LHRH and Ang II on prolactin stimulation are mediated by hypophysial AT1 receptor subtype. Am J Physiol Endocrinol Metab 266: E274-E278, 1994.
5. Bonnet F, Cooper ME, Carey RM, Casley D, and Cao Z. Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. J Hypertens 19: 1075-1081, 2001.
6. Brann DW, Rao I, and Mahesh VB. Antagonism of estrogen-induced prolactin release by progesterone. Biol Reprod 39: 1067-1073, 1988.
7. Brosnihan KB, Li P, Ganten D, and Ferrario CM. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol Regul Integr Comp Physiol 273: R1908-R1915, 1997.
8. Brue T, Pellegrini I, Priou A, Morange I, and Jaquet P. Prolactinomas and resistance to dopamine agonists. Horm Res 38: 84-89, 1992.
9. Carrière PD, De Léan A, Gutkowska J, Genest J, and Cantin M. Chronic estradiol treatment decreases angiotensin II receptor density in the anterior pituitary gland and adrenal cortex but not in the mesenteric artery. Neuroendocrinology 43: 49-56, 1986.
10. Chang K-J, Lee TTY, Linares-Cruz G, Fournier S, and De Lignieres B. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 63: 785-791, 1995.
11. Cho B, Suh Y, Yoon Y, Lee C, and Kim K. Progesterone inhibits the estrogen-induced prolactin gene expression in the rat pituitary. Mol Cell Endocrinol 93: 47-52, 1993.
12. Close FT and Freeman ME. Effects of ovarian steroid hormones on dopamine-controlled prolactin secretory responses in vitro. Neuroendocrinology 65: 430-435, 1997.
13. Deschepper CF. The renin-angiotensin system in the pituitary gland. Trends Endocrinol Metab 2: 104-107, 1991.
14. Diaz-Torga GS, Becu-Villalobos D, and Libertun C. Ontogeny of angiotensin-induced prolactin release in vivo and in vitro in female and male rats. Neuroendocrinology 59: 57-62, 1994.
15. 2+ mobilization and prolactin release in normal and hyperplastic pituitary cells. Am J Physiol Endocrinol Metab 274: E534-E540, 1998.
16. Dudley DT and Summerfelt RM. Regulated expression of angiotensin II (AT2) binding sites in R3T3 cells. Regul Pept 44: 199-206, 1993.
17. Ewert S, Laesser M, Johansson B, Holm M, Aneman A, and Fandriks L. The angiotensin II receptor type 2 agonist CGP 42112A stimulates NO production in the porcine jejunal mucosa. BMC Pharmacol 3: 2, 2003.
18. Goldenberg I, Grossman E, Jacobson KA, Shneyvays V, and Shainberg A. Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. J Hypertens 19: 1681-1689, 2001.
19. Gonzalez Iglesias A, Diaz-Torga G, Lux-Lantos V, Libertun C, and Becu-Villalobos D. Calcium influx and intracellular stores in angiotensin II stimulation of normal and hyperplastic pituitary cells. Am J Physiol Endocrinol Metab 277: E455-E463, 1999.
20. Gonzalez Iglesias A, Diaz-Torga G, Piroli G, Achaval-Zaia R, De Nicola AF, Libertun C, and Becu-Villalobos D. Bromocriptine restores angiotensin II response in pituitary hyperplasia. Mol Cell Endocrinol 165: 67-74, 2000.
21. 2+]i, inositol triphosphate, and prolactin in pituitary cells. Am J Physiol Endocrinol Metab 280: E462-E470, 2001.
22. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, and Navar LG. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 33: 340-346, 1999.
23. Healy DP, Ye M-Q, Yuan L-X, and Schachter BS. Stimulation of angiotensinogen mRNA levels in rat pituitary by estradiol. Am J Physiol Endocrinol Metab 263: E355-E361, 1992.
24. 2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 11: 1266-1277, 1997.
25. Horiuchi M, Lehtonen JYA, and Daviet L. Signaling mechanism of the AT2 angiotensin II receptor: crosstalk between AT1 and AT2 receptors in cell growth. Trends Endocrinol Metab 10: 391-395, 1999.
26. Hsueh AJW, Peck EJ, and Clark JH. Progesterone antagonism of the estrogen receptor and estrogen-induced uterine growth. Nature 254: 337-339, 1975.
27. Huang SW, Tsai SC, Tung YF, and Wang PS. Role of progesterone in regulating the effect of estradiol on the secretion of thyrotropin-releasing hormone and dopamine into hypophysial portal blood in ovariectomized rats. Neuroendocrinology 61: 536-541, 1995.
28. Inagami T, Guo DF, and Kitami Y. Molecular biology of angiotensin II receptors: an overview. J Hypertens Suppl 12: 583-594, 1994.
29. Iwai N and Inagami T. Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun 182: 1094-1099, 1992.
30. Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, and Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268: 24543-24546, 1993.
31. Lenkei Z, Nuyt AM, Grouselle D, Corvol P, and Llorens-Cortes C. Identification of endocrine cell population expressing the AT1B subtype of angiotensin II receptors in anterior pituitary. Endocrinology 140: 472-477, 1999.
32. Leri A, Fiordaliso F, Setoguchi M, Limana F, Bishopric NH, Kajstura J, Webster K, and Anversa P. Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis. Am J Pathol 157: 843-857, 2000.
33. Mancina R, Susini T, Renzetti A, Forti G, Razzoli E, Serio M, and Maggi M. Sex steroid modulation of AT2 receptors in human myometrium. J Clin Endocrinol Metab 81: 1753-1757, 1996.
34. Miyata N, Park F, Feng Li X, and Cowley AW. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol Renal Physiol 277: F437-F446, 1999.
35. Nora EH, Munzenmaier DH, Hansen-Smith FM, Lombard JH, and Greene AS. Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle. Am J Physiol Heart Circ Physiol 275: H1395-H1403, 1998.
36. 2 receptor. Trends Endocrinol Metab 11: 1-6, 2000.
37. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, and Carey RM. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30: 1238-1246, 1997.
38. Phillips MI, Wang H, Kimura B, Rejtman M, Koduri P, and Kalra SP. Dynamic changes in hypothalamic angiotensin II levels and release in association with progesterone-induced luteinizing hormone surge. Endocrinology 132: 1637-1642, 1993.
39. Piroli GG, Grillo CA, Ferrini MG, Lux-Lantos V, and De Nicola AF. Antagonism by progesterone of diethylstilbestrol-induced pituitary tumorigenesis in Fischer 344 rats: effects on sex steroid receptors and tyrosine hydroxylase mRNA. Neuroendocrinology 63: 530-539, 1996.
40. Pucell AG, Hodges JC, Sen I, Bumpus FM, and Husain A. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor. Endocrinology 128: 1947-1959, 1991.
41. Sanvitto GL, Johren O, Hauser W, and Saavedra JM. Water deprivation upregulates AngII AT1 binding and mRNA in rat subfornical organ and anterior pituitary. Am J Physiol Endocrinol Metab 273: E156-E163, 1997.
42. Seltzer A, Pinto JEB, Viglione PN, Correa FMA, Libertun C, Tsutsumi K, Steele MK, and Saavedra JM. Estrogens regulate angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology 55: 460-467, 1992.
43. Sharma M, Sharma R, Greene AS, McCarthy ET, and Savin VJ. Documentation of angiotensin II receptors in glomerular epithelial cells. Am J Physiol Renal Physiol 274: F623-F627, 1998.
44. Sharma R, Sharma M, Vamos S, Savin VJ, and Wiegmann TB. Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells. J Lab Clin Med 138: 40-49, 2001.
45. Shelat SG, King JL, Flanagan-Cato LM, and Fluharty SJ. Mineralocorticoids and glucocorticoids cooperatively increase salt intake and angiotensin II receptor binding in rat brain. Neuroendocrinology 69: 339-351, 1999.
46. Su JZ, Fukuda N, Jin XQ, Lai YM, Suzuki M, Tahira Y, Takagi H, Ikeda Y, Kanmatsuse K, and Miyazaki H. Effect of AT2 receptor on expression of AT1 and TGF-beta receptors in VSMCs from SHR. Hypertension 40: 853-858, 2002.
47. Suarez C, Diaz-Torga G, Gonzalez-Iglesias A, Vela J, Mladovan A, Baldi A, and Becu-Villalobos D. Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells. Am J Physiol Endocrinol Metab 285: E645-E653, 2003.
48. Subrahmanyam CS, Cassidy B, Busch H, and Rothblum LI. Nucleotide sequence of the region between the 18S rRNA sequence and the 28S rRNA sequence of rat ribosomal DNA. Nucleic Acids Res 10: 3667-3680, 1982.
49. Tanaka M, Tsuchida S, Imai T, Fujii N, Miyazaki H, Ichiki T, Naruse M, and Inagami T. Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem Biophys Res Commun 258: 194-198, 1999.
50. Tsai SC, Lu CC, Lau CP, Hwang GS, Lee HY, Chen SL, Huang SW, Shih HC, Chen YH, Chiao YC, Wang SW, and Wang PS. Progesterone stimulates in vitro release of prolactin and thyrotropin involving cAMP production in rat pituitary. Chin J Physiol 39: 245-251, 1996.
51. Unger T. The angiotensin type 2 receptor: variations on an enigmatic theme. J Hypertens 17: 1775-1786, 1999.
52. 2 receptors in the ovine fetal adrenal gland. Mol Cell Endocrinol 157: 161-170, 1999.
53. Ying C, Gregg DW, and Gorski J. Estrogen-induced changes in rRNA accumulation and RNA polymerase I activity in the rat pituitary: correlation with pituitary tumor susceptibility. Mol Cell Endocrinol 118: 213, 1996.